Natural Product Research
899
(1H, d, J ¼ 2.4 Hz, H-300), 6.24 (1H, d, J ¼ 2.4 Hz, H-500), 5.83 (1H, d, J ¼ 6.6 Hz, H-10), 5.73
(1H, brs, 50-OH), 5.71 (1H, d, J ¼ 7.8 Hz, H-5), 5.55 (1H, brs, 20-OH), 5.25 (1H, dd, J ¼ 5.4,
2.4 Hz, H-30), 4.36 (1H, dd, J ¼ 6.6, 5.4 Hz, H-20), 4.07 (1H, q, J ¼ 2.4 Hz, H-40), 3.70 (3H, s,
H-900), 3.64 (2H, m, H-50), 2.19 (3H, s, H-800). 13C NMR (DMSO-d6, 150 MHz, d, ppm): 166.4
(C, C-700), 162.8 (C, C-4), 159.5 (C, C-200), 159.5 (C, C-400), 150.6 (C, C-2), 140.2 (CH, C-6),
137.9 (C, C-600), 113.4 (C, C-100), 108.8 (CH, C-500), 102.1 (CH, C-5), 96.7 (CH, C-300), 85.7
(CH, C-10), 82.7 (CH, C-40), 73.2 (CH, C-30), 71.4 (CH, C-20), 60.9 (CH2, C-50), 55.4 (CH3, C-
900), 19.4 (CH3, C-800).
3.4. Preparation of acetylated derivatives of 3 and 4
To a solution of 3/4 (20 mg) in dry acetone (2.0 mL), Ac2O (100 mL) and K2CO3 (10 mg) were
added at RT, and the reaction mixture was stirred for 6 h. The solvent was evaporated in vacuo
and the residue was purified by semi-preparative HPLC eluting with 80% MeOH–H2O to give
3a (6.9 mg) and 4a (7.8 mg).
3.4.1. Diacetylkipukasin E (3a)
1
Colourless oil. H NMR (CDCl3, 600 MHz, d, ppm): 8.82 (1H, brs, 3-NH), 7.41 (1H, d,
J ¼ 8.4 Hz, H-6), 6.32 (2H, d, J ¼ 2.4 Hz, H-300, H-500), 6.10 (1H, d, J ¼ 6.0 Hz, H-10), 5.79 (1H,
dd, J ¼ 8.4, 1.8 Hz, H-5), 5.52 (1H, dd, J ¼ 6.0, 3.6 Hz, H-30), 5.42 (1H, t, J ¼ 6.0 Hz, H-20),
4.43–4.46 (2H, m, H-40, Ha-50), 4.37 (1H, dd, J ¼ 13.8, 3.6 Hz, Hb-50), 3.81 (6H, s, H-900, H-
1000), 2.31 (3H, s, H-800), 2.16 (3H, s, H-1100), 2.06 (3H, s, H-1300). ESI-MS m/z 529.1 [M þ Na]þ.
3.4.2. Diacetylkipukasin D (4a)
1
Colourless oil. H NMR (CDCl3, 600 MHz, d, ppm): 8.53 (1H, brs, 3-NH), 7.42 (1H, d,
J ¼ 8.4 Hz, H-6), 6.31 (1H, d, J ¼ 1.8 Hz, H-300 or H-500), 6.29 (1H, d, J ¼ 1.8 Hz, H-500 or H-300)
6.07 (1H, d, J ¼ 5.4 Hz, H-10), 5.79 (1H, dd, J ¼ 8.4, 1.8 Hz, H-5), 5.56 (1H, t, J ¼ 5.4 Hz, H-30
or H-20), 5.43 (1H, t, J ¼ 5.4 Hz, H-20 or H-30), 4.34–4.39 (3H, m, H-40, H-50), 3.80 (3H, s, H-900
or H-1000), 3.76 (3H, s, H-1000 or H-900), 2.29 (3H, s, Hþ-800), 2.16 (3H, s, H-1100 or H-1300), 2.08
(3H, s, H-1300 or H-1100). ESI-MS m/z 529.1 [M þ Na] .
3.5. Biological assays
The antibacterial assay was carried out as described previously (Pierce et al. 2008). Seven
bacterial strains were used, including Bacillus cereus (ACCC 11077), Micrococcus luteus
(ATCC 49732), S. epidermidis (ATCC 12228), Staphylococcus aureus (ATCC 27154),
Escherichia coli (ATCC 25922), Vibrio parahemolyticus (ATCC 17802) and Pseudomonas
putida (ATCC 49128), and ciprofloxacin was used as a positive control. The brine shrimp
lethality assay was performed on A. salina according to the published protocols (Meyer et al.
1982; Solis et al. 1993). DMSO was used as a positive control. The cytotoxic activities against
human erythroleukaemia K562 and human promyelocytic leukaemia HL-60 cell lines were
determined by the MTT method (Mosmann 1983). Adriamycin was used as a positive control.
Supplementary material
1
The 1D and 2D NMR, and MS spectra of 1/2, the H NMR and MS spectra of 3a and 4a and
1
selected H–1H COSY and HMBC correlations for 1 are available online.